Shares of Orchid Pharma Ltd shot-up 9% higher on 6 June after the company announced receiving approval from the Drugs Controller General of India (DCGI)...
On Friday, the Drugs Controller General of India (DCGI) has given its market approval to the drug Lynparza (Olaparib) as a monotherapy for the adjuvant...
Zydus has announced biological therapy ZRC-3308, used to treat mild COVID-19. The pharmaceutical company now seeks DCGI (Drugs Controller General of India) nod to undertake...